Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis
article
OA: hybrid
CC0
⤵ 22 in-corpus citations
AI-generated summary
This study found that β-glucuronidase, elevated in endometriosis lesions, promotes endometrial cell proliferation and lesion development in mice, partly via macrophage dysfunction.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo explore the role of gut dysbiosis-derived β-glucuronidase (GUSB) in the development of endometriosis (EMs).Design16S rRNA sequencing of stool samples from women with (n = 35) or without (n = 30) endometriosis and from a mouse model was conducted to assess gut microbiome changes and identify molecular factors influencing the development of endometriosis. Experiments in vivo in an endometriosis C57BL6 mouse model and in vitro verified the level of GUSB and its role in the development of EMs.SettingDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University; Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases.Patient(s)Women of reproductive age with a histological diagnosis of endometriosis were enrolled in the endometriosis group (n = 35) and infertile or healthy age-matched women who had undergone a gynecological or radiological examination in the control group (n = 30). Fecal and blood samples were taken the day before surgery. Paraffin-embedded sections from 50 bowel endometriotic lesions, 50 uterosacral lesions, 50 samples without lesions, and 50 normal endometria were collected.Intervention(s)None.Main Outcome Measure(s)Changes in the gut microbiome of patients with EMs and mice and the effect of β-glucuronidase on the proliferation and invasion of endometrial stromal cells and the development of endometriotic lesions were assessed.Result(s)No difference in α and β diversity was found between patients with EMs and controls. Immunohistochemistry analysis showed higher β-glucuronidase expression in bowel lesions and uterosacral ligament lesions than in the normal endometrium (p<0.01). β-Glucuronidase promoted the proliferation and migration of endometrial stromal cells during cell counting kit-8, Transwell, and wound-healing assays. Macrophage levels, especially M2, were higher in bowel lesions and uterosacral ligament lesions than in controls, and β-glucuronidase promoted the M0 to M2 transition. Medium conditioned by β-glucuronidase-treated macrophages promoted endometrial stromal cell proliferation and migration. β-Glucuronidase increased the number and volume of endometriotic lesions and number of macrophages present in lesions in the mouse EMs model.Conclusion(s)This β-Glucuronidase promoted EMs development directly or indirectly by causing macrophage dysfunction. The characterization of the pathogenic role of β-glucuronidase in EMs has potential therapeutic implications. To explore the role of gut dysbiosis-derived β-glucuronidase (GUSB) in the development of endometriosis (EMs). 16S rRNA sequencing of stool samples from women with (n = 35) or without (n = 30) endometriosis and from a mouse model was conducted to assess gut microbiome changes and identify molecular factors influencing the development of endometriosis. Experiments in vivo in an endometriosis C57BL6 mouse model and in vitro verified the level of GUSB and its role in the development of EMs. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University; Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases. Women of reproductive age with a histological diagnosis of endometriosis were enrolled in the endometriosis group (n = 35) and infertile or healthy age-matched women who had undergone a gynecological or radiological examination in the control group (n = 30). Fecal and blood samples were taken the day before surgery. Paraffin-embedded sections from 50 bowel endometriotic lesions, 50 uterosacral lesions, 50 samples without lesions, and 50 normal endometria were collected. None. Changes in the gut microbiome of patients with EMs and mice and the effect of β-glucuronidase on the proliferation and invasion of endometrial stromal cells and the development of endometriotic lesions were assessed. No difference in α and β diversity was found between patients with EMs and controls. Immunohistochemistry analysis showed higher β-glucuronidase expression in bowel lesions and uterosacral ligament lesions than in the normal endometrium (p<0.01). β-Glucuronidase promoted the proliferation and migration of endometrial stromal cells during cell counting kit-8, Transwell, and wound-healing assays. Macrophage levels, especially M2, were higher in bowel lesions and uterosacral ligament lesions than in controls, and β-glucuronidase promoted the M0 to M2 transition. Medium conditioned by β-glucuronidase-treated macrophages promoted endometrial stromal cell proliferation and migration. β-Glucuronidase increased the number and volume of endometriotic lesions and number of macrophages present in lesions in the mouse EMs model. This β-Glucuronidase promoted EMs development directly or indirectly by causing macrophage dysfunction. The characterization of the pathogenic role of β-glucuronidase in EMs has potential therapeutic implications.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (54)
- Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota via openalex
- Autonomic nervous system and inflammation interaction in endometriosis-associated pain via openalex
- Elevated heme impairs macrophage phagocytosis in endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and inflammatory bowel disease: A systematic review of the literature via openalex
- Endometriosis and irritable bowel syndrome: similarities and differences in the spectrum of comorbidities via openalex
- Endometriosis and the microbiome: a systematic review via openalex
- Endometriosis induces gut microbiota alterations in mice via openalex
- Endometriosis is associated with an altered profile of intestinal microflora in female rhesus monkeys via openalex
- Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis via openalex
- Interleukin‐22 secreted by ectopic endometrial stromal cells and natural killer cells promotes the recruitment of macrophages through promoting CCL2 secretion via openalex
- Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
- Potential Role of Semaphorin 3A and Its Receptors in Regulating Aberrant Sympathetic Innervation in Peritoneal and Deep Infiltrating Endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls via openalex
- The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain via openalex
- Villainous role of estrogen in macrophage-nerve interaction in endometriosis via openalex
- W2883649579 via openalex
- W2912325577 via openalex
- W2943168969 via openalex
- W2945777288 via openalex
- W2960146403 via openalex
- W2970287716 via openalex
- W2989779964 via openalex
- W2994175683 via openalex
- W3036016649 via openalex
- W3192403241 via openalex
- W3193146573 via openalex
- W3193922083 via openalex
- W3199735725 via openalex
- W4224600442 via openalex
- W4234160457 via openalex
- W4247365520 via openalex
- W6663474901 via openalex
- W6736046848 via openalex
- W6799753688 via openalex
- W198775781 via openalex
- W6801010491 via openalex
- W1918028620 via openalex
- W2013305106 via openalex
- W2025785529 via openalex
- W2039231261 via openalex
- W2133017002 via openalex
- W2140145798 via openalex
- W2175951661 via openalex
- W2587755289 via openalex
- W2605950351 via openalex
- W2612215129 via openalex
- W2640475594 via openalex
- W2754456799 via openalex
- W2761875562 via openalex
- W2775573455 via openalex
- W2800949001 via openalex
- W2801765418 via openalex
Cited by (23)
- Gut microbiota dysbiosis in endometriosis: mechanistic insights and gut microbiota-targeted therapeutic strategies 2026
- TICAM1-Mediated TLR3/TLR4 Signaling Promotes Endometrial Stromal Cell Proliferation, Migration, and Invasion in Endometriosis via IRF3/IFN-β Axis 2026
- Broadening horizons: microbiota as a novel biomarker and potential treatment for endometriosis 2025
- Gut feeling: understanding the endometriosis-digestive link to enhance patient care and symptom control 2025
- Gut Microbiota Profile in Endometriosis Patients at Dr. M. Djamil Padang, West Sumatra, Indonesia 2025
- OTUD1 inhibits endometriosis fibrosis by deubiquitinating MADH7 2025
- The Endobiota-estrobolome Study in Reproductive aged Women with Ovarian Endometriosis 2024
- Gut microbiome in endometriosis: a cohort study on 1,000 individuals 2024
- Causal effects between gut microbiota and endometriosis: a two-sample Mendelian randomisation study 2024
- Additional file 2 of Gut microbiome in endometriosis: a cohort study on 1000 individuals 2024
- Additional file 2 of Gut microbiome in endometriosis: a cohort study on 1000 individuals 2024
- Additional file 1 of Gut microbiome in endometriosis: a cohort study on 1000 individuals 2024
- Additional file 1 of Gut microbiome in endometriosis: a cohort study on 1000 individuals 2024
- Role of the gut microbiota in the pathogenesis of endometriosis: a review 2024
- Endometriosis: A Comprehensive Analysis of the Pathophysiology, Treatment, and Nutritional Aspects, and Its Repercussions on the Quality of Life of Patients 2024
- Gut microbiome in endometriosis: a cohort study on 1000 individuals 2024
- Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis 2024
- Relationship between the gut microbiome and endometriosis and its role in pathogenesis, diagnosis, and treatment: a systematic review 2023
- Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications 2023
- Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments 2023
- Gut Microbiome–Estrobolome Profile in Reproductive-Age Women with Endometriosis 2023
- Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together—A Review 2023
- The effect of the female genital tract and gut microbiome on reproductive dysfunction 2023
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-01T00:33:45.861436+00:00
License: CC0
· commercial use OK